Royal Bank of Canada Issues Pessimistic Forecast for Select Medical (NYSE:SEM) Stock Price

Select Medical (NYSE:SEM) had its target price cut by equities researchers at Royal Bank of Canada from $47.00 to $23.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the health services provider’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 20.07% from the company’s previous close.

SEM has been the topic of several other reports. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price objective on the stock in a research report on Monday. StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Finally, UBS Group reduced their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $27.25.

Select Medical Trading Up 3.4 %

Shares of Select Medical stock opened at $19.16 on Monday. Select Medical has a 52-week low of $16.20 and a 52-week high of $40.98. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The company’s 50-day simple moving average is $19.07 and its 200-day simple moving average is $27.81. The firm has a market cap of $2.48 billion, a price-to-earnings ratio of 11.61, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.11). The firm had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. As a group, equities research analysts anticipate that Select Medical will post 1.17 earnings per share for the current year.

Insiders Place Their Bets

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 19.14% of the stock is owned by company insiders.

Hedge Funds Weigh In On Select Medical

A number of large investors have recently bought and sold shares of the business. Quarry LP bought a new position in Select Medical in the 3rd quarter worth about $30,000. Smartleaf Asset Management LLC grew its holdings in Select Medical by 179.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider’s stock worth $43,000 after buying an additional 1,473 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Select Medical in the 3rd quarter valued at approximately $81,000. Covestor Ltd boosted its position in Select Medical by 33.5% during the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider’s stock worth $93,000 after acquiring an additional 1,244 shares during the period. Finally, Lazard Asset Management LLC grew its stake in shares of Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider’s stock worth $130,000 after purchasing an additional 2,255 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.